Notice: Our website will be down for maintenance from June 13 - June 14.

Biogen Idec and Sobi See Progress in Pediatric Hemophilia B Study

This is an edited version of a press release from Biogen Idec. To read the full release, please click here.____________________Biogen Idec  and Swedish Orphan Biovitrum AB announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of ALPROLIX®Â [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in children under age 12 […]

en_USEnglish